Booz Allen Becomes Health Level Seven, Inc. (HL7) Benefactor

Annual Report

Our Clients & Our Work

Assurance and Resilience

Economic and Business Analysis

Information Technology

Intelligence & Operations Analysis

Modeling and Simulation

Organization and Strategy

Supply Chain and Logistics

Systems Engineering and Integration

Doing Business with Booz Allen

Small Business Program

Vendor Relations

Booz Allen in the News

Media Inquiries

Press Releases

Search Jobs

Create & Update Profile

Why Work for Booz Allen

Featured Opportunities

Cleared-Intelligence Professionals

Experienced Professionals

University Recruiting

Internships

Home > Booz Allen Becomes Health Level Seven, Inc. (HL7) Benefactor

Printer Friendly

Booz Allen Becomes Health Level Seven, Inc. (HL7) Benefactor
Firm to support development of industry-critical standards and products.

Health Level Seven Press Release

Ann Arbor, MI (October 17, 2006) — Health Level Seven, Inc. (HL7) today announced that Booz Allen Hamilton has become the organization’s latest benefactor member. As an HL7 benefactor member, Booz Allen Hamilton provides financial support to HL7 for development of industry-critical standards and products.

“I am grateful for Booz Allen Hamilton’s support of HL7’s vital role in developing healthcare information standards and am delighted to welcome them as an HL7 benefactor,” said HL7 Chairman Chuck Meyer. “Booz Allen Hamilton’s engagement with the National Cancer Institute’s cancer Biomedical Informatics Grid, or caBIG, initiative puts them on the leading edge of informatics standards development and implementation. Having the support of such a forward-thinking organization will be of great benefit to Health Level Seven and its efforts to bring semantic interoperability to the exchange of healthcare information.”

“Booz Allen is pleased to be an HL7 benefactor,” said Robin Portman, vice president at Booz Allen Hamilton. “Booz Allen recognizes that the future of healthcare and research depends on interoperability. We need to be thought leaders in the standards game to make this future a reality.”

Booz Allen Hamilton joins 33 other HL7 benefactor members including: Accenture; Boston Scientific Corporation; Centers for Disease Control and Prevention; Duke Clinical Research Institute (DCRI); Eclipsys Corporation; Eli Lilly & Company; Epic Systems Corporation; the Food and Drug Administration; GE Healthcare Information Technologies; GlaxoSmithKline; IBM; Intel Corporation; InterSystems Corporation; Kaiser Permanente; McKesson Provider Technologies; Microsoft Corporation; Misys Healthcare Systems; NHS Connecting for Health; NICTIZ National Healthcare; Novartis; Oracle Corporation; Partners HealthCare System, Inc.; Pfizer, Inc.; Philips Medical Systems; Quest Diagnostics Inc.; Science Applications International Corporation; Siemens Medical Solutions Health Services; Solucient, LLC.; St. Jude Medical; the U.S. Department of Defense, Military Health System; the U.S. Department of Veterans Affairs; and Wyeth Pharmaceuticals.

Employees | Alumni